Ever thought about using tech for a better night's sleep? The Sleep Show might be for you. Courtesy of the Sleep Show

Tech has affected every aspect of our lives, from the way we get our groceries or order food to how we meet a mate. So, it only makes sense that there is developing technology focused on improving the way we sleep.

This weekend, the Sleep Show is taking over George R. Brown Convention Center in downtown Houston, and 28 sleep tech products are competing on Saturday, March 9, for the National Sleep Foundation's SleepTech Award. Here are 10 of the award's semi-finalists that aren't snoozing on innovation.

TimeShifter 

Courtesy of the Sleep Show

Jetlag is a thing of the past if you use TimeShifter before, during, and after your trip. You program your plans in the app, and it offers you advice and recommendations for overcoming jetlag.

SleepScore

Photo via sleepscore.com

Another free app, SleepScore delivers advice and analytics for your regular night's sleep. the program is backed by science and doesn't require the user to wear anything or put anything in their bed. A bedside monitor us also used to detect light or sound in the bedroom for better analytics.

Embr

Courtesy of the Sleep Show

Everybody has their own optimized sleeping temperature, and it's difficult to control it from a larger scale heating and cooling system. The Embr Wave, developed by MIT scientists, is a personal thermostat you wear on your wrist. There's no bright screen either, and users simply press and hold the device if they are too hot or too cold.

Biostrap

Photo via biostrap.com

Another wearable, Biostrap is a sleep and fitness tracker that can provide precise vitals — such as heartbeat — using a clinical-quality PPG sensor, which runs on light-based technology. The data can be used for sleep analysis, heart rate, heart rate variability, blood oxygen saturation, and respiratory rate.

Kryo Inc.'s ChiliPad

Courtesy of the Sleep Show

The ChiliPad is for sleepers who need to chill out. The blanket, which is the size of half of a queen bed — perfect for couples with different temperature needs — can regulate temperatures between 55 and 110 degrees.

Somnox

Courtesy of the Sleep Show

​Touted as the world's first sleep robot, the Somnox Sleep Robot is your high-tech cuddle buddy and little spoon. It syncs your breathing to that of the machine's and puts you straight into a relaxed state with soothing sounds. You can program your robot for a night's sleep, a quick nap, or just a relaxation period. You also tell the robot how long you want the sleep synchronization for, before it automatically shuts off.

BreatheSimple

Photo via breathesimple.com

Another breathing technology is BreatheSimple, a free app that helps train you to optimize your breathing. The app is currently available on iOS, and will soon be an option for Android users.

Nanit

Photo via nanit.com

Babies need sleep tech too, and Nanit as an over-the-crib monitor made to record, track, and offer guidance for parents on their baby's sleeping. The device was actually named by TIME Magazine as one of the "Best Inventions of 2018".

URGONight

Photo via urgonight.com

You can train yourself to be a better sleeper with URGONight. The headpiece syncs with a mobile app and, in about three months, you'll be a professional sleeper.

SonicTonic

Photo via sonictonic.io

Sounds are so important to humans' ability to relax. SonicTonic aims to help users truly relax their minds for a good night's rest and treat anxiety, depression, phobias, and more.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”